GlassScriptPhysician profile
Yu-Kuan Lin
NPI 1063706414
$6,171.83
in general payments reported to CMS, 2019-2025
52 companies · $1,428 in 2025
The $1,428 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $770 · 2020: $544 · 2021: $550 · 2022: $685 · 2023: $1,040 · 2024: $1,155 · 2025: $1,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,488 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,487.91 |
| Education | $135.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $854.58 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Sumitomo Pharma America, INC. | $534.20 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $427.00 | 2022-2025 | Erleada, Tremfya |
| Astellas Pharma US INC | $410.92 | 2019-2025 | Xtandi, Myrbetriq |
| Neotract INC. | $282.61 | 2019-2020 | |
| Abbvie INC. | $278.98 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $239.67 | 2019-2024 | |
| Urogen Pharma, INC. | $197.06 | 2022-2025 | Jelmyto |
| Ferring Pharmaceuticals INC. | $171.18 | 2019-2025 | Adstiladrin |
| Pfizer INC. | $164.68 | 2019-2024 | |
| Intercept Pharmaceuticals, INC. | $152.19 | 2024-2025 | |
| Travere Therapeutics, INC. | $147.26 | 2019-2021 | |
| Lilly USA, LLC | $142.82 | 2023-2025 | Taltz, Omvoh, Zepbound |
| Coloplast Corp | $123.98 | 2019-2024 | Speedicath |
| Medtronic, INC. | $120.85 | 2021-2025 | Interstim |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $116.11 | 2023-2025 | Entyvio |
| Myriad Genetic Laboratories, INC. | $107.50 | 2021-2024 | Prolaris, Myrisk |
| Halozyme INC | $98.16 | 2023 | |
| Merck Sharp & Dohme LLC | $97.79 | 2022-2025 | Keytruda, Keytruda Qlex |
| Endo Pharmaceuticals INC. | $94.40 | 2022-2023 | Xiaflex |
| 180 Medical, INC. | $91.57 | 2021-2025 | Gentlecath |
| Boston Scientific Corporation | $86.54 | 2019-2023 | Ams 700 Cxr Rte Kit |
| Progenics Pharmaceuticals, INC. | $84.30 | 2023-2025 | Pylarify |
| Astrazeneca Pharmaceuticals LP | $78.42 | 2021-2025 | Imfinzi, Saphnelo |
| Myovant Sciences INC. | $76.25 | 2021-2022 | |
| Axonics, INC. | $72.29 | 2020-2023 | Axonics |
| Telix Pharmaceuticals | $72.17 | 2024-2025 | Illuccix |
| Teleflex LLC | $71.70 | 2023-2024 | Urolift |
| Endo USA, INC. | $69.95 | 2024-2025 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $66.18 | 2019-2024 | Aquabeam System |
| Medtronic USA, INC. | $60.35 | 2020 | |
| Blue Earth Diagnostics | $56.59 | 2024-2025 | Posluma |
| Therapeuticsmd, INC. | $52.09 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $49.47 | 2019-2024 | Bard Urinary Drainage Bag |
| Amgen INC. | $40.47 | 2022-2023 | Enbrel, Otezla |
| Aimmune Therapeutics, INC. | $39.36 | 2025 | Zenpep |
| Alnylam Pharmaceuticals INC. | $38.04 | 2023 | Givlaari |
| Urovant Sciences INC | $34.78 | 2022 | |
| Laborie Medical Technologies Corp. | $28.71 | 2023 | |
| Acerus Pharmaceuticals Corporation | $27.93 | 2021 | |
| Alexion Pharmaceuticals, INC. | $22.76 | 2023 | Strensiq |
| Fresenius Kabi USA, LLC | $22.44 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $20.03 | 2024 | Arcalyst |
| Olympus America INC. | $18.67 | 2023 | Itind System |
| Verity Pharmaceuticals INC. | $18.54 | 2024 | Tlando |
| Braintree Laboratories, INC. | $18.20 | 2021 | |
| Tempus Ai, INC | $17.79 | 2025 | Xt Cdx |
| Nestle Healthcare Nutrition INC. | $17.32 | 2022 | |
| Allergan, INC. | $15.28 | 2021 | |
| Phathom Pharmaceuticals, INC. | $15.25 | 2025 | Voquezna |
| Clarus Therapeutics INC. | $14.00 | 2021 | |
| Rochester Medical Corporation | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yu-Kuan Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.